Latest Breaking News On - Dirk witter - Page 1 : comparemela.com

ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming financial reporting activities.

San franciscoUnited statesChris buyseDirk witterImmunoprecise antibodie lensaiMitch levineAudit committee of hyloris pharmaceuticalsNomination committeeAudit committeeAudit committee of inventivaShemano groupMember of enable capital managementContract research organizationAnnual general meetingManaging memberEnable capital management